IT1262545B - Sistema di espressione per linee cellulari eucariotiche - Google Patents

Sistema di espressione per linee cellulari eucariotiche

Info

Publication number
IT1262545B
IT1262545B ITFI930212A ITFI930212A IT1262545B IT 1262545 B IT1262545 B IT 1262545B IT FI930212 A ITFI930212 A IT FI930212A IT FI930212 A ITFI930212 A IT FI930212A IT 1262545 B IT1262545 B IT 1262545B
Authority
IT
Italy
Prior art keywords
cell lines
expression system
eukaryotic cell
csf
preparation
Prior art date
Application number
ITFI930212A
Other languages
English (en)
Inventor
Antonio Mele
Luigi Rotondaro
Original Assignee
Menarini Ricerche Sud S P A A
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Menarini Ricerche Sud S P A A filed Critical Menarini Ricerche Sud S P A A
Priority to ITFI930212A priority Critical patent/IT1262545B/it
Publication of ITFI930212A0 publication Critical patent/ITFI930212A0/it
Priority to PCT/EP1994/003488 priority patent/WO1995011982A1/en
Priority to AU79395/94A priority patent/AU7939594A/en
Publication of ITFI930212A1 publication Critical patent/ITFI930212A1/it
Application granted granted Critical
Publication of IT1262545B publication Critical patent/IT1262545B/it

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/53—Colony-stimulating factor [CSF]
    • C07K14/535—Granulocyte CSF; Granulocyte-macrophage CSF
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biophysics (AREA)
  • Medicinal Chemistry (AREA)
  • Zoology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

E' descritto un processo per la preparazione di G-CSF umano ricombinante per il quale viene usato un vettore comprendente almeno uno del seguenti elementi: (1) un promotore CMV a monte di una sequenza di DNA codificante la proteina desiderato, (2) una sequenza per il processamento dei trascritti di m RNA, e (3) una sequenza di marcatura (marker) per la selezione e l'amplificazione. Inoltre, è descritto l'uso di tale G-CSF umana ricombinante per la preparazione di composizioni farmaceutiche per provocare l'ematopoiesi, per il miglioramento dei meccanismi di difesa contro le infezioni e per la stimolazione e superproduzione di cellule effettrici funzionali contro tumori maligni.
ITFI930212A 1993-10-25 1993-10-25 Sistema di espressione per linee cellulari eucariotiche IT1262545B (it)

Priority Applications (3)

Application Number Priority Date Filing Date Title
ITFI930212A IT1262545B (it) 1993-10-25 1993-10-25 Sistema di espressione per linee cellulari eucariotiche
PCT/EP1994/003488 WO1995011982A1 (en) 1993-10-25 1994-10-24 Expression system for eukaryotic cell lines
AU79395/94A AU7939594A (en) 1993-10-25 1994-10-24 Expression system for eukaryotic cell lines

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
ITFI930212A IT1262545B (it) 1993-10-25 1993-10-25 Sistema di espressione per linee cellulari eucariotiche

Publications (3)

Publication Number Publication Date
ITFI930212A0 ITFI930212A0 (it) 1993-10-25
ITFI930212A1 ITFI930212A1 (it) 1995-04-25
IT1262545B true IT1262545B (it) 1996-07-02

Family

ID=11350637

Family Applications (1)

Application Number Title Priority Date Filing Date
ITFI930212A IT1262545B (it) 1993-10-25 1993-10-25 Sistema di espressione per linee cellulari eucariotiche

Country Status (3)

Country Link
AU (1) AU7939594A (it)
IT (1) IT1262545B (it)
WO (1) WO1995011982A1 (it)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ITFI940106A1 (it) * 1994-05-27 1995-11-27 Menarini Ricerche Sud Spa Molecola ibrida di formula gm-csf-l-epo o epo-l-gm-csf per la stimolaz ione eritropoietica
IT1303683B1 (it) * 1998-10-30 2001-02-23 Menarini Ricerche Spa Composizione farmaceutiche ad azione antitumorale contenente dnacodificante per frammenti di una proteina antigenica.
GB0216648D0 (en) 2002-07-18 2002-08-28 Lonza Biologics Plc Method of expressing recombinant protein in CHO cells
JP5502406B2 (ja) * 2009-09-14 2014-05-28 ロンザ・バイオロジクス・ピーエルシー Ｃｈｏ細胞において組換えタンパク質を発現する方法

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS63105675A (ja) * 1986-10-23 1988-05-10 Green Cross Corp:The ヒトウロキナ−ゼの製造方法
GB8717430D0 (en) * 1987-07-23 1987-08-26 Celltech Ltd Recombinant dna product

Also Published As

Publication number Publication date
WO1995011982A1 (en) 1995-05-04
ITFI930212A1 (it) 1995-04-25
ITFI930212A0 (it) 1993-10-25
AU7939594A (en) 1995-05-22

Similar Documents

Publication Publication Date Title
US4822605A (en) Compositions and methods employing the same for the treatment of viral and cancerous skin lesions and the like
DK0559884T3 (da) Rekombinante virusvektorer til ekspression i muskelceller
DE60332358D1 (de) Protease-resistente modifizierte interferon alpha polypeptide
NO952744L (no) Cytokinbegrensende midler
AU9084601A (en) G-csf analog compositions and methods
NO963837D0 (no) Nye muteiner av IFN-
IE64765B1 (en) Use of cytokines
NZ320889A (en) A p35 protein which binds to and inhibits chemokines
WO2022256498A9 (en) Msln targeting trispecific proteins and methods of use
MX2023002047A (es) Proteinas de interleucina 2 (il-2) glucosiladas y usos de las mismas.
BR0009170A (pt) ácidos nucléicos akt, polipeptìdeos e uso dos mesmos
Friedman et al. Translation of RNA by L cell extracts: Effect of interferon
WO2022256500A3 (en) Dll3 targeting trispecific proteins and methods of use
IT1262545B (it) Sistema di espressione per linee cellulari eucariotiche
NO20060675L (no) Forbedrede, rekombinante, humane interferon-beta-lb-polypeptider
ATE238427T1 (de) Vektoren, die therapeutische gene fuer antimikrobielle peptide enthalten, zur verwendung in der gentherapie
TR200100430T2 (tr) Tyrosine kinase SRC kullanılan angiogenesisin modülasyonu için yararlı metot ve bileşimler.
BR9815496A (pt) Vacinas de ácido nucléico que codificam proteìna gde vìrus sincicial respiratório
WO2013187552A1 (ko) 알로페론을 포함하는 항염증 약학적 조성물 및 화장료 조성물
US20110286966A1 (en) Inhibitor of Endogenous Human Interferon-gamma
MX2022016389A (es) Conjugados de citocina.
SI1537204T1 (sl) Granzim b kot povzročitelj apoptoze odvisen od peptida Hsp Hsp v tumorskih celicah
HUP0300787A2 (hu) Új interferon a sclerosis multiplex kezelésére
AR014884A1 (es) Uso de un conjugado de angiotensina inmunogenico y composicion farmaceutica
Greenberg Human interferon in viral diseases

Legal Events

Date Code Title Description
0001 Granted
TA Fee payment date (situation as of event date), data collected since 19931001

Effective date: 19971030